Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Berlex now marketing Levulan Kerastick photodynamic therapy in U.S.

Dec. 13, 2000

FDA approves Protopic for the treatment of eczema

Dec. 11, 2000

NicOx's HCT-1026 shows promise for treatment of skin inflammation

Nov. 29, 2000

Dusa moves Levulan into phase I/II for the treatment of acne

Nov. 29, 2000

Phytopharm begins phase II trial of P-45 for alopecia areata

Nov. 28, 2000

Angiotech begins phase II trial with micellar paclitaxel for psoriasis

Nov. 27, 2000

Licensing opportunity from NIH: smad3 protein inhibition to enhance wound healing

Nov. 20, 2000

Steroid-free eczema treatment recommended for FDA approval

Nov. 17, 2000

Cellegy seeks approval of Rectogesic in New Zealand

Nov. 15, 2000

MBI-594AN advances to phase II for treatment of acne

Nov. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...